AI龋齿检测工具临床可部署性评估:结构化叙事综合与框架建议
多数为回顾性单数据集研究,以A型为主,侧重区分度指标而临床使用关键信息不足;无研究达到C型。作者提出七柱框架用于评估临床可部署性。
要点
- 现有AI龋齿检测研究多侧重区分度指标,临床可部署性关键信息常缺失。
- 七柱框架涵盖人群匹配、校准、验证完整性、参考标准、稳健性与工作流治理。
- 无研究达到监管 clearance 与部署级验证的C型证据标准。
核心结论
- 当前证据基础强调区分度指标,但常遗漏安全、可解释和可治理临床使用所需的关键要素。
- 评估应纳入患病率背景、校准与阈值、验证完整性、参考标准、稳健性及工作流/治理。
- 七柱框架为临床医生、采购人员和监管者评估市售AI工具提供实用视角。
研究设计与样本
- 对评估咬翼片AI龋齿检测的同行评审研究进行结构化叙事综合。
- 报告映射至七个可部署性领域,并将研究分为A-C描述性证据类型。
主要发现
- A型证据类型占主导(33项研究),报告区分度但多个临床使用领域信息有限。
- B型证据类型较少(6项研究),验证实践更强(含患者层面分离和/或外部验证),但校准和患病率敏感报告仍存差距。
- 无研究满足C型标准(记录监管 clearance 与部署级验证),限制从发表来源独立评估商业就绪度。
临床怎么用
- 临床评估AI龋齿检测工具时,应结合患病率背景、校准与阈值、验证完整性、参考标准、稳健性及工作流/治理七方面综合判断。
- 采购和监管人员可参考七柱框架审评市售AI工具,避免仅依赖区分度指标。
局限性
- 多数纳入研究为回顾性单数据集评估,证据类型以A型为主。
- 无研究达到C型证据标准,无法从发表来源独立评估商业就绪度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To synthesise how studies evaluating AI-based caries detection on bitewing radiographs report evidence relevant to real-world clinical use beyond discrimination metrics (e.g., sensitivity, specificity, and area under the curve [AUC]), and to propose a structured appraisal framework for assessing clinical deployability. METHODS: A structured narrative synthesis of peer-reviewed studies evaluating AI-based caries detection on bitewing radiographs was conducted. Reporting was mapped to seven deployability domains (population fit/prevalence, calibration/thresholding, predictive values, validation integrity, reference standards, robustness, and workflows/governance), and studies were grouped into descriptive evidence profiles (Types A-C). RESULTS: Thirty-nine studies met the inclusion criteria. Most were retrospective single-dataset evaluations. Type A evidence profiles predominated (33 studies), characterised by reporting of discrimination but limited information across several clinical-use domains. Type B profiles were less common (6 studies) and showed stronger validation practices (including patient-level separation and/or external validation) but persistent gaps in calibration and prevalence-sensitive reporting. No study met the criteria for Type C (documented regulatory clearance with deployment-level validation), limiting independent appraisal of commercial readiness from published sources. CONCLUSIONS: The current evidence base emphasises discrimination metrics but frequently omits key elements required for safe, interpretable, and governable clinical use. Appraisal should incorporate prevalence context, calibration and thresholds, validation integrity, reference standards, robustness and workflow/governance. The seven-pillar framework provides a pragmatic lens for clinicians, procurement officers, and regulators appraising marketed AI tools.
引用
- Hegde S, Vasa R. Assessing the clinical deployability of AI tools for caries detection: A structured narrative synthesis and proposed framework. J Dent. 2026. PMID: 42162784. doi:10.1016/j.jdent.2026.106770
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。